EyeTube

Does Preoperative Anti-VEGF Change Outcomes in Non-Tractional Vitreous Hemorrhage? Show Description + What happens when vitreous hemorrhage (VH) secondary to non-tractional PDR doesn't clear on its own? And does preoperative anti-VEGF actually change surgical outcomes?

Explore what retina specialists see in the OR by watching videos in an immersive 3D experience. Go to 3D Videos

“CLARE, is that you?” Show Description + Imagine this: “You have a new patient on your schedule who has a red eye. It is painful, they’re light sensitive, their vision is blurry, and they just slept in their contact lenses!” This probably isn’t so hard to imagine. To see whether you’d handle this patient the same way Dr. Allen would, watch this latest episode of “Eye Care Insiders”. Financial disclosure: Alcon, Amazon, Bausch + Lomb, Harrow, MYZE, Nanodropper.

Comparing Ocular AEs in Next-Gen Treatments ; ; Show Description + What can pharmacovigilance data tell us about the post-marketing safety profiles of anti-VEGF agents, and where do those signals fall short?

Combined Scleral Buckle and Vitrectomy for Pseudophakic Retinal Detachment Show Description + Hudson Nakamura, MD, demonstrates combined scleral buckle and pars plana vitrectomy for repair of a pseudophakic retinal detachment. Combined Scleral Buckle and Vitrectomy for Pseudophakic Retinal Detachment Hudson Nakamura, MD, demonstrates combined scleral buckle and pars plana vitrectomy for repair of a pseudophakic retinal detachment.

Angle-Based MIGS for a Patient With Severe Glaucoma ; ; Show Description + John Berdahl, MD; Tanner Ferguson, MD; and Mitch Ibach, OD, FAAO, discuss a case of a male patient with memory issues, progressive visual field loss, and elevated IOP. He has a history of cataract surgery and MIGS but was lost to follow-up and is not on any antiglaucoma medication.

Secondary IOL Surgery Is Unprofitable Under Current Medicare Reimbursement Rates. Now What? Show Description + How much money are retina surgeons losing on secondary IOL procedures? In this episode of Clinical Minute: Retina, host Maria Berrocal, MD, speaks with Nimesh "Nemo" Patel, MD, whose research uncovered how many cases are unprofitable under current Medicare reimbursement rates, and assess how much cash surgeons burn per case.

When a Minimally Invasive Procedure Fails ; ; Show Description + Iqbal Ike K. Ahmed, MD, FRCSC, and Arsham Sheybani, MD, sit down with Rachel G. Simpson, MD, to reflect on the role of trabeculectomy in today’s glaucoma treatment landscape. They discuss the importance of minimally invasive surgical approaches but emphasize the need to keep trabeculectomy from becoming a lost art.

Innovations in Glaucoma: The FYSX OPAP Device ; Show Description + John Berdahl, MD, inventor of the FYSX O-PAP (Ocular Pressure Adjusting Pump), joins the set of Innovation Journal Club to share insights on the device, pearls for patient selection, and tips for using it in practice. Dr. Berdahl also discusses data from the pivotal trial of the FYSX device, which showed IOP lowering in 100% of eyes with normal tension glaucoma.

Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of American Society of Retina Specialists Annual Meeting.